Two promising therapies to treat patients with acute megakaryocytic leukemia (AMKL) was identified by investigators at Northwestern University Feinberg School of Medicine. AMKL is a rare form of leukemia where the number of cases is expected to increase with the aging population. The disease is characterized by an overload of white blood cells that remain forever young because they can't mature into specialized cells. Published in a recent issue of the journal ...Friday 21 September 2012
Tough Types of Leukemias Get Doubly Assaulted
Two promising therapies to treat patients with acute megakaryocytic leukemia (AMKL) was identified by investigators at Northwestern University Feinberg School of Medicine. AMKL is a rare form of leukemia where the number of cases is expected to increase with the aging population. The disease is characterized by an overload of white blood cells that remain forever young because they can't mature into specialized cells. Published in a recent issue of the journal ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment